However, new evidence points to its activity within the coagulation cascade, interfering with antithrombin/SERPINC1 and factor XIIa leading to increased coagulation indicating an increased tendency for procoagulant disorders in COVID-19 patients [41]. The gene discussed is SERPINC1; the disease is COVID-19.